Please login to the form below

Not currently logged in
Email:
Password:

Sigma-Tau Pharmaceuticals

This page shows the latest Sigma-Tau Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Sigma-Tau Pharmaceuticals appoints Dave Lemus chief operating officer

Sigma-Tau Pharmaceuticals appoints Dave Lemus chief operating officer. He takes over from Gregg Lapointe who has resigned. ... President of Sigma-Tau Pharmaceuticals Professor Trevor Jones said: "We are delighted to appoint Dave to lead our efforts to

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch table for July 2014 Deal Watch table for July 2014

    3, 080. Cosmo Technologies/ Salix Pharmaceuticals. Merger (tax inversion). Portfolio of treatments for gastrointestinal disease and disorders. ... 360. Sigma-Tau/ Jazz Pharmaceuticals. Regaining rights. Defibrotide for severe hepatic veno-occlusive

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Sigma-Tau Pharmaceuticals appoints CEO Sigma-Tau Pharmaceuticals appoints CEO

    Sigma-Tau Pharmaceuticals appoints CEO. Interim CEO Michael Minarich takes up the post in a permanent capacity. ... Rare disease specialist Sigma-Tau Pharmaceuticals has appointed Michael Minarich as chief executive officer.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics